TissGeneSummary for DDIT4 |
Gene summary |
Basic gene information | Gene symbol | DDIT4 |
Gene name | DNA-damage-inducible transcript 4 | |
Synonyms | Dig2|REDD-1|REDD1 | |
Cytomap | UCSC genome browser: 10q22.1 | |
Type of gene | protein-coding | |
RefGenes | NM_019058.2, | |
Description | DNA damage-inducible transcript 4 proteinHIF-1 responsive protein RTP801protein regulated in development and DNA damage response 1 | |
Modification date | 20141207 | |
dbXrefs | MIM : 607729 | |
HGNC : HGNC | ||
Ensembl : ENSG00000168209 | ||
HPRD : 09662 | ||
Vega : OTTHUMG00000183961 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DDIT4 | |
BioGPS: 54541 | ||
Pathway | NCI Pathway Interaction Database: DDIT4 | |
KEGG: DDIT4 | ||
REACTOME: DDIT4 | ||
Pathway Commons: DDIT4 | ||
Context | iHOP: DDIT4 | |
ligand binding site mutation search in PubMed: DDIT4 | ||
UCL Cancer Institute: DDIT4 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | CervixOvary | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | CESCOV | |
Reference showing the relevant tissue of DDIT4 | ||
Description by TissGene annotations | Have significant anti-correlated miRNA TissgsLTS Fused withOncogene Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0001666 | response to hypoxia | 20166753 | GO:0001666 | response to hypoxia | 20166753 |
Top |
TissGeneExp for DDIT4 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
PRAD | 0.976912917 | 2.200941763 | -1.224028846 | 1.62E-08 | 1.91E-07 |
COAD | 1.791218686 | 0.492695609 | 1.298523077 | 2.31E-08 | 1.87E-07 |
HNSC | 3.052912335 | 1.813840242 | 1.239072093 | 2.24E-06 | 1.54E-05 |
KIRC | 3.390317083 | 1.295174028 | 2.095143056 | 1.13E-25 | 1.42E-24 |
LUAD | 2.299148261 | 1.135608606 | 1.163539655 | 3.29E-07 | 1.19E-06 |
LUSC | 2.508614387 | 1.44324772 | 1.065366667 | 8.69E-05 | 0.000181371 |
Top |
TissGene-miRNA for DDIT4 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
UCS | hsa-miR-199b-3p | MIMAT0004563 | 0.022 | -0.31 | 56 |
UCS | hsa-miR-199a-3p | MIMAT0000232 | 0.023 | -0.31 | 56 |
UCS | hsa-miR-92b-3p | MIMAT0003218 | 0.014 | -0.33 | 56 |
Top |
TissGeneMut for DDIT4 |
TissGeneSNV for DDIT4 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.G75R | LUSC | 1 |
p.D27H | CESC | 1 |
p.H158Y | LUAD | 1 |
p.H91R | UCEC | 1 |
p.S224L | BLCA | 1 |
p.S111F | PAAD | 1 |
p.E90G | LUAD | 1 |
p.E152K | STAD | 1 |
p.P66S | PRAD | 1 |
p.A37V | LUSC | 1 |
p.S32L | BLCA | 1 |
p.S77P | SKCM | 1 |
p.S52W | LIHC | 1 |
p.P2S | LUAD | 1 |
p.Y136C | LUAD | 1 |
p.R143W | UCEC | 1 |
p.L179Q | PRAD | 1 |
p.H91N | KICH | 1 |
Top |
TissGeneCNV for DDIT4 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for DDIT4 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BE772578 | AZGP1P1-DDIT4 | chr7:99580876 | chr10:74034947 | |
Chimerdb3.0 | ChiTaRs | NA | DW438966 | H19-DDIT4 | chr11:2018969 | chr10:74035655 | |
Chimerdb3.0 | ChiTaRs | NA | CB162888 | DDIT4-DDIT4 | chr10:74034737 | chr10:74034744 | |
Chimerdb3.0 | ChiTaRs | NA | BQ773488 | NUDCD3-DDIT4 | chr7:44507966 | chr10:74034858 | |
Chimerdb3.0 | ChiTaRs | NA | BE774996 | DDIT4-CSNK1D | chr10:74035603 | chr17:80209314 | |
Chimerdb3.0 | ChiTaRs | NA | BF930964 | NDRG2-DDIT4 | chr14:21487891 | chr10:74035024 |
Top |
TissGeneNet for DDIT4 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for DDIT4 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for DDIT4 |
TissGeneDrug for DDIT4 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for DDIT4 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0041341 | Tuberous Sclerosis | 6 | BeFree,LHGDN |
umls:C0006142 | Malignant neoplasm of breast | 3 | BeFree |
umls:C0678222 | Breast Carcinoma | 3 | BeFree |
umls:C0002395 | Alzheimer's Disease | 2 | BeFree,LHGDN |
umls:C0029925 | Ovarian Carcinoma | 2 | BeFree |
umls:C0242383 | Age related macular degeneration | 2 | BeFree |
umls:C0596263 | Carcinogenesis | 2 | BeFree |
umls:C1140680 | Malignant neoplasm of ovary | 2 | BeFree |
umls:C0003130 | Anoxia | 1 | LHGDN |
umls:C0003469 | Anxiety Disorders | 1 | BeFree |
umls:C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
umls:C0007137 | Squamous cell carcinoma | 1 | LHGDN |
umls:C0023418 | leukemia | 1 | BeFree,CTD_human |
umls:C0023467 | Leukemia, Myelocytic, Acute | 1 | BeFree |
umls:C0023470 | Myeloid Leukemia | 1 | BeFree |
umls:C0026636 | Mouth Diseases | 1 | CTD_human |
umls:C0026764 | Multiple Myeloma | 1 | BeFree |
umls:C0027746 | Nerve Degeneration | 1 | CTD_human |
umls:C0030567 | Parkinson Disease | 1 | CTD_human |
umls:C0033578 | Prostatic Neoplasms | 1 | LHGDN |
umls:C0034067 | Pulmonary Emphysema | 1 | BeFree |
umls:C0041696 | Unipolar Depression | 1 | BeFree |
umls:C0151514 | Atrophic condition of skin | 1 | BeFree |
umls:C0206701 | Cystadenocarcinoma, Serous | 1 | BeFree |
umls:C0242350 | Erectile dysfunction | 1 | BeFree |
umls:C0346429 | Multiple malignancy | 1 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 1 | BeFree |
umls:C0600139 | Prostate carcinoma | 1 | BeFree |
umls:C1168401 | Squamous cell carcinoma of the head and neck | 1 | BeFree |
umls:C1269683 | Major Depressive Disorder | 1 | BeFree |
umls:C1559271 | Non-Malignant Ascites Adverse Event | 1 | BeFree |